Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01864291 · ClinicalTrials.gov registry record · NA
Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects
A NA study, sponsored by Massachusetts Eye and Ear Infirmary.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT01864291 is a NA study that was terminated before completion, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 9 participants.
The verdict
NCT01864291, a NA study, was terminated before completion, sponsored by Massachusetts Eye and Ear Infirmary.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether Auditory Brainstem Implant (ABI) can improve hearing in children who are deaf and cannot receive a cochlear implants.
Interventions
- DEVICE Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2013-05 |
| Est. Completion | 2019-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01864291
The ClinicalTrials.gov registry entry for NCT01864291 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI) is the first listed.
NCT01864291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01864291 about?
NCT01864291 is a clinical study titled "Auditory Brainstem Implant (ABI) in Pediatric Non-Neurofibromatosis Type 2 Subjects". The purpose of this research study is to determine whether Auditory Brainstem Implant (ABI) can improve hearing in children who are deaf and cannot receive a cochlear implants.
What is the current status of trial NCT01864291?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2013-05. Estimated completion is 2019-04-25.
What interventions are being tested in trial NCT01864291?
The interventions under investigation include: Nucleus 24 (discontinued) and ABI541 Auditory Brainstem Implants (ABI) (DEVICE).
Who is sponsoring clinical trial NCT01864291?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.